Retraction Note: A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function

by Jeremy To, Doug Quackenbush, Emily Rowell, Lilin Li, Connor Reed, Frederick Lo, Shane R. Horman
Published 2021-08-01

A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function

by Jeremy To, Doug Quackenbush, Emily Rowell, Lilin Li, Connor Reed, Frederick Lo, Shane R. Horman
Published 2021-01-01

856 INBRX-106: a novel hexavalent anti-OX40 agonist for the treatment of solid tumors

by Quinn Deveraux, Heather Kinkead, Kyle Jones, Bryan Becklund, Florian Sulzmaier, John Timmer, Brendan Eckelman, Analeah Heidt, William Crago, Emily Rowell, Elisabeth Torretti
Published 2021-11-01

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

by Jason Ho, Chelsie Macedo, Garrett Cyprus, Rajay Pandit, Anya Polovina, Nadja Kern, Abrahim Hussain, Sae Jeong Ahn, William Crago, Emily Rowell, Florian J Sulzmaier, John C Timmer, Brendan P Eckelman
Published 2023-01-01